Literature DB >> 11719794

Pulmonary nitric oxide in mountain dwellers.

C M Beall1, D Laskowski, K P Strohl, R Soria, M Villena, E Vargas, A M Alarcon, C Gonzales, S C Erzurum.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11719794     DOI： 10.1038/35106641

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  52 in total

1.  Brain blood flow in Andean and Himalayan high-altitude populations: evidence of different traits for the same environmental constraint.

Authors:  Gerard F A Jansen; Buddha Basnyat
Journal:  J Cereb Blood Flow Metab       Date:  2010-08-25       Impact factor: 6.200

Review 2.  Metabolic changes through hypoxia in humans and in yeast as a comparable cell model.

Authors:  Nikolaus C Netzer; Michael Breitenbach
Journal:  Sleep Breath       Date:  2010-06-10       Impact factor: 2.816

Review 3.  Nitric oxide in adaptation to altitude.

Authors:  Cynthia M Beall; Daniel Laskowski; Serpil C Erzurum
Journal:  Free Radic Biol Med       Date:  2012-01-20       Impact factor: 7.376

4.  Lessons in hypoxic adaptation from high-altitude populations.

Authors:  Kingman P Strohl
Journal:  Sleep Breath       Date:  2008-05       Impact factor: 2.816

5.  Higher blood flow and circulating NO products offset high-altitude hypoxia among Tibetans.

Authors:  S C Erzurum; S Ghosh; A J Janocha; W Xu; S Bauer; N S Bryan; J Tejero; C Hemann; R Hille; D J Stuehr; M Feelisch; C M Beall
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-30       Impact factor: 11.205

6.  Two routes to functional adaptation: Tibetan and Andean high-altitude natives.

Authors:  Cynthia M Beall
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-09       Impact factor: 11.205

7.  Enhanced NO-dependent pulmonary vasodilation limits increased vasoconstrictor sensitivity in neonatal chronic hypoxia.

Authors:  Joshua R Sheak; Laura Weise-Cross; Ray J deKay; Benjimen R Walker; Nikki L Jernigan; Thomas C Resta
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-07-21       Impact factor: 4.733

8.  Phosphodiesterase type 5 and high altitude pulmonary hypertension.

Authors:  A A Aldashev; B K Kojonazarov; T A Amatov; T M Sooronbaev; M M Mirrakhimov; N W Morrell; J Wharton; M R Wilkins
Journal:  Thorax       Date:  2005-08       Impact factor: 9.139

Review 9.  Update on the clinical utility of sildenafil in the treatment of pulmonary arterial hypertension.

Authors:  Gautam V Ramani; Myung H Park
Journal:  Drug Des Devel Ther       Date:  2010-05-25       Impact factor: 4.162

10.  Endogenous nitric oxide and pulmonary circulation response to hypoxia in high-altitude adapted Tibetan sheep.

Authors:  Zonghai Ruan; Tomonobu Koizumi; Akio Sakai; Takeshi Ishizaki; Zhangang Wang
Journal:  Eur J Appl Physiol       Date:  2004-08-14       Impact factor: 3.078
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.